Comments
Loading...
Cyclerion Therapeutics (NASDAQ:CYCN) Stock, Earnings Estimates, EPS, And Revenue
Cyclerion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.290
Quarterly Revenue
$194K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$194K
Analyze the earnings history of Cyclerion Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cyclerion Therapeutics (CYCN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2022 | 2023-03-22 | $-3.20 | $-5.60 | 42.9 % |
Cyclerion Therapeutics (CYCN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Cyclerion Therapeutics (NASDAQ:CYCN) reporting earnings?
Cyclerion Therapeutics (CYCN) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Cyclerion Therapeutics (NASDAQ:CYCN)?
The Actual EPS was $-0.29, which missed the estimate of $0.00.
What were Cyclerion Therapeutics’s (NASDAQ:CYCN) revenues?
The Actual Revenue was $194K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.